Skip to main content
. Author manuscript; available in PMC: 2016 Apr 27.
Published in final edited form as: Am J Surg Pathol. 2009 May;33(5):669–681. doi: 10.1097/PAS.0b013e318194c566

FIGURE 5.

FIGURE 5

Representative immunoprofile of tumors evaluated in this study included in the morphologic differential diagnosis of chordoid meningioma. Extraskeletal myxoid chondrosarcoma: (A) D2-40 negative, (B) S100 positive, (C) pankeratin positive (patchy, weak), and (D) EMA negative. Chordoma: (E) D2-40 negative, (F) S100 positive, (G) pankeratin positive, and (H) EMA positive. Low-grade chondrosarcoma, enchondroma, and skeletal myxoid chondrosarcoma: (I/M/Q) D2-40 positive, (J/N/R) S100 positive, (K/O/S) pankeratin negative, and (L/P/T) EMA negative. Chordoid glioma: (U) D2-40 positive, (V) S100 positive, (W) pankeratin positive, and (X) EMA positive. EMA indicates epithelial membrane antigen.